» Articles » PMID: 25297643

Role of Prophylactic Vitamin K in Preventing Antibiotic Induced Hypoprothrombinemia

Overview
Specialty Pediatrics
Date 2014 Oct 10
PMID 25297643
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine prophylactic role of single dose of vitamin K in prevention of antibiotic induced hypoprothrombinemia.

Methods: This prospective comparative study included critically ill children in age group 2 mo to 12 y, admitted to a tertiary care hospital in India, likely to receive prolonged antibiotic therapy. One hundred twenty children, 60 in each group (A & B) were enrolled in the study. Patient allocation was done on alternate basis. Group A children received prophylactic vitamin K while group B did not. Baseline coagulation studies and other investigations were done in all children. Coagulation studies were repeated on day 10 and day 14 of antibiotic therapy and in between if required clinically. Children who developed deranged INR were given therapeutic vitamin K. If deranged INR returns to normal at 12 h of vitamin K administration then it indirectly confirms vitamin K deficiency. Analysis was done by fisher's t test and chi square test.

Results: In children on prolonged antibiotic therapy, vitamin K deficiency was a common problem (15%). It was common in male sex, severe grade of protein energy malnutrition (PEM), N-methylthiotetrazole (NMTT) group containing antibiotics use and duration of antibiotic more than 10 d. It was same in children whether they received or did not receive prophylactic vitamin K on day 1 of antibiotic therapy (95% CI; p value 0.79).

Conclusions: Vitamin K deficiency is common problem in patients on prolonged antibiotic therapy. There is no role of single dose of prophylactic vitamin K in preventing antibiotic induced hypoprothrombinemia.

Citing Articles

Vitamin K: a potential missing link in critical illness-a scoping review.

Paulus M, Drent M, Kouw I, Balvers M, Bast A, van Zanten A Crit Care. 2024; 28(1):212.

PMID: 38956732 PMC: 11218309. DOI: 10.1186/s13054-024-05001-2.


Coagulopathy Induced by Antibiotics Usage and Bowel Obstruction With Colon Cancer: Report of a Rare Case.

Fujiwara S, Akaishi R, Yokosawa T, Suzuki H, Hoshida T Cureus. 2024; 16(1):e52865.

PMID: 38406074 PMC: 10889475. DOI: 10.7759/cureus.52865.


Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study.

Wang Q, Liang P, Xu Y, Yuan B, Lan C, Yan X Eur J Clin Pharmacol. 2024; 80(5):737-746.

PMID: 38353692 PMC: 11001783. DOI: 10.1007/s00228-024-03634-4.


Micronutrient status in children aged 6-59 months with severe wasting and/or nutritional edema: implications for nutritional rehabilitation formulations.

Vresk L, Flanagan M, Daniel A, Potani I, Bourdon C, Spiegel-Feld C Nutr Rev. 2024; 83(1):112-145.

PMID: 38350491 PMC: 11632376. DOI: 10.1093/nutrit/nuad165.


Right femoral vein and right dorsal artery thrombosis in childhood acute myeloid leukemia: A case report.

Ni J, Chen M, Su Y, Gao Q, Liu L, Lu X Medicine (Baltimore). 2023; 102(41):e35121.

PMID: 37832057 PMC: 10578772. DOI: 10.1097/MD.0000000000035121.


References
1.
Nichols R, Wikler M, McDevitt J, Lentnek A, Hosutt J . Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections. Antimicrob Agents Chemother. 1987; 31(2):281-5. PMC: 174706. DOI: 10.1128/AAC.31.2.281. View

2.
Welage L, Hejmanowski L, Wilton J, Walawander C, RIGAN D, Williams J . Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan. Antimicrob Agents Chemother. 1989; 33(6):857-61. PMC: 284245. DOI: 10.1128/AAC.33.6.857. View

3.
Lipsky J . Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics. Proc Natl Acad Sci U S A. 1984; 81(9):2893-7. PMC: 345179. DOI: 10.1073/pnas.81.9.2893. View

4.
BARKHAN P, Shearer M . Metabolism of vitamin K1 (phylloquinone) in man. Proc R Soc Med. 1977; 70(2):93-6. PMC: 1542956. View

5.
Olson R, Chao J, Graham D, Bates M, Lewis J . Total body phylloquinone and its turnover in human subjects at two levels of vitamin K intake. Br J Nutr. 2002; 87(6):543-53. DOI: 10.1079/BJNBJN2002565. View